Journal of Oncology / 2014 / Article / Tab 5

Review Article

The Efficacy of Bisphosphonates in Preventing Aromatase Inhibitor Induced Bone Loss for Postmenopausal Women with Early Breast Cancer: A Systematic Review and Meta-Analysis

Table 5

Heterogeneity test results.

Outcome value

Bone pain0.608
Back pain0.744
Pain in extremity0.056
LS BMD 12 months (normal at baseline-ZOL trials)0.0003
LS BMD 12 months (osteopenic at baseline-ZOL trials)0.296
LS BMD 12 months (residronate and ibandronate trials)0.345